Published :
Tables : 53
Figures : 50
Category : Healthcare
No. of Pages : 247
Report Code : HC-U3121
C-Reactive Protein Test (CRP) Market is expected to grow at a CAGR of 1.3% from the forecast period 2020-2027. FutureWise Market Research has instantiated a report that report provides an intricate analysis of the Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market. According to the research study conducted by FutureWise research analysts, the Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the C-Reactive Protein Test (CRP) Market long with the growth opportunities present across this business vertical. Major players included in the Market are: • Thermo Fisher Scientific, Inc. • F. Hoffmann-La Roche Ltd. • Danaher • Quest Diagnostics Incorporated • Siemens • Abbott Laboratories • Laboratory Corporation of America Holdings • Merck KGaA • Abaxis, Inc. • Ortho Clinical Diagnostics • Getein Biotech, Inc. • HORIBA, Ltd. • Randox Laboratories Ltd. • BODITECH MED, INC • Aidian • Eurolyser Diagnostica GmbH • Abcam plc. • Bio-Techne • EKF Diagnostics • SD Biosensor, Inc. (Note: The list of the major players will be updated with the latest market scenario and trends) C-Reactive Protein Test (CRP) Market Segmentation: By Assay Type • ELISA o Clinical o Nonclinical • Immunoturbidimetric • CLIA • Others By Detection Range • hs-CRP • Conventional CRP • cCRP By Disease Area • Cardiovascular Diseases • Cancer • Rheumatoid Arthritis • Inflammatory Bowel Disease • Endometriosis • Lupus • Others By End User • Clinics o By Entity • Physician Offices • Small Clinics • Others o By Settings • Urban Setting • Rural Setting • Hospitals o Urban Setting o Rural Setting • Laboratories o Urban Setting o Rural Setting • Assisted Living Healthcare Facilities o Urban Setting o Rural Setting • Home • Others By Region • North America • Europe • Asia-Pacific • Rest of the world Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Market By Assay Type, By Detection Range, By Disease Area, By End User and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization services offered are free of charge with purchase of any license of the report. • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that report provides an intricate analysis of the Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market. According to the research study conducted by FutureWise research analysts, the Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the C-Reactive Protein Test (CRP) Market long with the growth opportunities present across this business vertical.
Major players included in the Market are:
• Thermo Fisher Scientific, Inc. • F. Hoffmann-La Roche Ltd. • Danaher • Quest Diagnostics Incorporated • Siemens • Abbott Laboratories • Laboratory Corporation of America Holdings • Merck KGaA • Abaxis, Inc. • Ortho Clinical Diagnostics • Getein Biotech, Inc. • HORIBA, Ltd. • Randox Laboratories Ltd. • BODITECH MED, INC • Aidian • Eurolyser Diagnostica GmbH • Abcam plc. • Bio-Techne • EKF Diagnostics • SD Biosensor, Inc. (Note: The list of the major players will be updated with the latest market scenario and trends)
C-Reactive Protein Test (CRP) Market Segmentation:
By Assay Type
• ELISA o Clinical o Nonclinical • Immunoturbidimetric • CLIA • Others
By Detection Range
• hs-CRP • Conventional CRP • cCRP
By Disease Area
• Cardiovascular Diseases • Cancer • Rheumatoid Arthritis • Inflammatory Bowel Disease • Endometriosis • Lupus • Others
By End User
• Clinics o By Entity • Physician Offices • Small Clinics • Others o By Settings • Urban Setting • Rural Setting • Hospitals o Urban Setting o Rural Setting • Laboratories o Urban Setting o Rural Setting • Assisted Living Healthcare Facilities o Urban Setting o Rural Setting • Home • Others
By Region • North America • Europe • Asia-Pacific • Rest of the world
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Market By Assay Type, By Detection Range, By Disease Area, By End User and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization services offered are free of charge with purchase of any license of the report. • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global C-Reactive Protein Test (CRP) Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global C-Reactive Protein Test (CRP) Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of C-Reactive Protein Test (CRP) Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global C-Reactive Protein Test (CRP) Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global C-Reactive Protein Test (CRP) Market, By Assay Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. ELISA 7.1.1. Clinical 7.1.2. Nonclinical 7.2. Immunoturbidimetric 7.3. CLIA 7.4. Others 8. Global C-Reactive Protein Test (CRP) Market, By Detection Range Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. hs-CRP 8.2. Conventional CRP 8.3. cCRP 9. Global C-Reactive Protein Test (CRP) Market, By Disease Area Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Cardiovascular Diseases 9.2. Cancer 9.3. Rheumatoid Arthritis 9.4. Inflammatory Bowel Disease 9.5. Endometriosis 9.6. Lupus 9.7. Others 10. Global C-Reactive Protein Test (CRP) Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Clinics 10.1.1. By Entity 10.1.1.1. Physician Offices 10.1.1.2. Small Clinics 10.1.1.3. Others 10.1.2. By Settings 10.1.2.1. Urban Setting 10.1.2.2. Rural Setting 10.2. Hospitals 10.2.1. Urban Setting 10.2.2. Rural Setting 10.3. Laboratories 10.3.1. Urban Setting 10.3.2. Rural Setting 10.4. Assisted Living Healthcare Facilities 10.4.1. Urban Setting 10.4.2. Rural Setting 10.5. Home 10.6. Others 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2020-2027 12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2020-2027 13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2020-2027 14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2020-2027 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Thermo Fisher Scientific, Inc. 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. F. Hoffmann-La Roche Ltd. 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Danaher 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Quest Diagnostics Incorporated 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Siemens 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Abbott Laboratories 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Laboratory Corporation of America Holdings 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Merck KGaA 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Abaxis, Inc. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Ortho Clinical Diagnostics 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11.Getein Biotech, Inc. 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12.HORIBA, Ltd. 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13.Randox Laboratories Ltd. 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14.BODITECH MED, INC 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 17.15.Aidian 17.15.1. Company Overview 17.15.2. Product Portfolio 17.15.3. SWOT Analysis 17.15.4. Financial Overview 17.15.5. Strategic Overview 17.16.Eurolyser Diagnostica GmbH 17.16.1. Company Overview 17.16.2. Product Portfolio 17.16.3. SWOT Analysis 17.16.4. Financial Overview 17.16.5. Strategic Overview 17.17.Abcam plc. 17.17.1. Company Overview 17.17.2. Product Portfolio 17.17.3. SWOT Analysis 17.17.4. Financial Overview 17.17.5. Strategic Overview 17.18.Bio-Techne 17.18.1. Company Overview 17.18.2. Product Portfolio 17.18.3. SWOT Analysis 17.18.4. Financial Overview 17.18.5. Strategic Overview 17.19.EKF Diagnostics 17.19.1. Company Overview 17.19.2. Product Portfolio 17.19.3. SWOT Analysis 17.19.4. Financial Overview 17.19.5. Strategic Overview 17.20.SD Biosensor, INC. 17.20.1. Company Overview 17.20.2. Product Portfolio 17.20.3. SWOT Analysis 17.20.4. Financial Overview 17.20.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global C-Reactive Protein Test (CRP) Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global C-Reactive Protein Test (CRP) Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of C-Reactive Protein Test (CRP) Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global C-Reactive Protein Test (CRP) Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global C-Reactive Protein Test (CRP) Market, By Assay Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. ELISA 7.1.1. Clinical 7.1.2. Nonclinical 7.2. Immunoturbidimetric 7.3. CLIA 7.4. Others 8. Global C-Reactive Protein Test (CRP) Market, By Detection Range Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. hs-CRP 8.2. Conventional CRP 8.3. cCRP 9. Global C-Reactive Protein Test (CRP) Market, By Disease Area Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Cardiovascular Diseases 9.2. Cancer 9.3. Rheumatoid Arthritis 9.4. Inflammatory Bowel Disease 9.5. Endometriosis 9.6. Lupus 9.7. Others 10. Global C-Reactive Protein Test (CRP) Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Clinics 10.1.1. By Entity 10.1.1.1. Physician Offices 10.1.1.2. Small Clinics 10.1.1.3. Others 10.1.2. By Settings 10.1.2.1. Urban Setting 10.1.2.2. Rural Setting 10.2. Hospitals 10.2.1. Urban Setting 10.2.2. Rural Setting 10.3. Laboratories 10.3.1. Urban Setting 10.3.2. Rural Setting 10.4. Assisted Living Healthcare Facilities 10.4.1. Urban Setting 10.4.2. Rural Setting 10.5. Home 10.6. Others 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2020-2027 12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2020-2027 13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2020-2027 14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2020-2027
16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Thermo Fisher Scientific, Inc. 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. F. Hoffmann-La Roche Ltd. 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Danaher 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Quest Diagnostics Incorporated 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Siemens 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Abbott Laboratories 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Laboratory Corporation of America Holdings 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Merck KGaA 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Abaxis, Inc. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Ortho Clinical Diagnostics 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11.Getein Biotech, Inc. 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12.HORIBA, Ltd. 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13.Randox Laboratories Ltd. 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14.BODITECH MED, INC 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 17.15.Aidian 17.15.1. Company Overview 17.15.2. Product Portfolio 17.15.3. SWOT Analysis 17.15.4. Financial Overview 17.15.5. Strategic Overview 17.16.Eurolyser Diagnostica GmbH 17.16.1. Company Overview 17.16.2. Product Portfolio 17.16.3. SWOT Analysis 17.16.4. Financial Overview 17.16.5. Strategic Overview 17.17.Abcam plc. 17.17.1. Company Overview 17.17.2. Product Portfolio 17.17.3. SWOT Analysis 17.17.4. Financial Overview 17.17.5. Strategic Overview 17.18.Bio-Techne 17.18.1. Company Overview 17.18.2. Product Portfolio 17.18.3. SWOT Analysis 17.18.4. Financial Overview 17.18.5. Strategic Overview 17.19.EKF Diagnostics 17.19.1. Company Overview 17.19.2. Product Portfolio 17.19.3. SWOT Analysis 17.19.4. Financial Overview 17.19.5. Strategic Overview 17.20.SD Biosensor, INC. 17.20.1. Company Overview 17.20.2. Product Portfolio 17.20.3. SWOT Analysis 17.20.4. Financial Overview 17.20.5. Strategic Overview
18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics